Académique Documents
Professionnel Documents
Culture Documents
LYMPHOCYTES 34 % 20-40
Whole Blood EDTA, Flowcytometry
Page 1 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 09:14PM
Barcode No 10195842
RDW- SD 51.2 fl 35-56
Whole Blood EDTA, Flowcytometry
Page 2 of 8
ITDOSE INFOSYSTEMS PVT. LTD.
KIDNEY PANEL- 2
BLOOD UREA 23.9 mg/dL 17-43
Serum, Urease, GLDH
LIPID PROFILE
CHOLESTEROL 187.6 mg/dl <200
Serum, CHOD-PAP Enzymatic
Page 3 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842
HDL / LDL RATIO 0.43 >0.3
Serum, Calculated
Comment:
Lipids are a group of fats and fat-like substances that are important constituents of cells and sources of energy. The lipid profile is used as part of a
cardiac risk assessment to help determine an individual's risk of heart disease. It is recommended that healthy adults with no other risk factors for
heart disease be tested with a fasting lipid profile once every four to six years. If other risk factors are present or if previous testing revealed a high
cholesterol level in the past, more frequent testing is recommended.
BORDERLINE HIGH 200-239 HIGH >60 NEAROPTIMAL 100-129 BORDERLINE HIGH 150-199
VERYHIGH >190
Page 4 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842
GAMMA G.T. 54 IU/L <40
Serum, Kinetic with IFCC
Comment:
A liver panel (Liver function test) or one or more of its component tests may be used to help diagnose liver disease if a person has symptoms that indicate possible liver
dysfunction. If a person has a known condition or liver disease, testing may be performed at intervals to monitor liver status and to evaluate the effectiveness of any
treatments.
COMMENT:
Hypersensitive TSH test is use to screen for and help diagnose thyroid disorders; to monitor treatment of hypothyroidism and hyperthyroidism. TSH levels are
usually increased in hypothyroidism and decreased in hyperthyroidism.
Ourreferencerangeappliesthecentral95thinterval(2.5th97.5thquantile)accordingtotheCLSI/IFCCguidelinesEP28-A3c.
A circadian variation in serum TSH in healthy subjects is well documented. TSH level is reaching peak levels between 2-4 am and at a minimum between 6-
10 pm. The variation is of the order of 50%, hence time of the day has influence on the value of TSH.
TSH levels between 5.5 and 15.0 may represent subclinical or compensated hypothyroidism or show considerable physiological & seasonal variation, suggest
clinical correlation or repeat testing with fresh sample.
TSH levels may be transiently altered because of non-thyroid illness, like severe infection, renal disease, liver disease, heart disease, severe burns, trauma,
surgery etc. Few drugs also altered the TSH values.
The combination of Free T3, Free T4 and third generation TSH offer a powerful tool for the efficient and differential diagnosis and management of thyroid disorders. Free T3 and Free
T4 estimation are unaffected by changes in Thyroid Binding Globulins (TBG). A decrease in serum Free T3 and Free T4 and increase in TSH confirms the diagnosis of
Hypothyroidism. Diagnosis of Hyperthyroidism can reliable be made in patients with low TSH and elevated Free T3 and Free T4 levels.
Page 5 of 8
Lab Id. 021704100028 Reg No 163189
Patient Name MS.SAMINA YASMIN 328223 Reg Date 10/Apr/2017 10:45AM
Age/Sex 54 YRS/Female Sample Coll. Date 10/Apr/2017 08:30AM
Refered By Dr. HEALTHIAN 08 Sample Rec.Date 10/Apr/2017 10:57AM
Client Code/Name AP000006 HEALTHIANS NET
Ref. Source Report Date 10/Apr/2017 02:31PM
Barcode No 10195842
>20 years 2.0 - 4.4 0.85 - 1.86 0.27 - 6.33
Method : Fully Automated Bidirectionally Interfaced Electro Chemi Luminescent Immuno Assay
Page 6 of 8
ITDOSE INFOSYSTEMS PVT. LTD.
MICROSCOPIC EXAMINATION
PUS CELLS. 1-2 /HPF 3-5
Urine, Microscopy
.
The tests marked with an * are not accredited by NABL.
Page 7 of 8
ITDOSE INFOSYSTEMS PVT. LTD.
Comments:
This test is used to determine the levels of 25-hydroxy-vitamin D and is used to determine if bone weakness, bone malformation, or abnormal metabolism of calcium is
occurring as a result of a deficiency or excess of vitamin D. Since vitamin D is a fat-soluble vitamin and is absorbed from the intestine like a fat, vitamin D is also s used
to monitor individuals with diseases that interfere with fat absorption, such as cystic fibrosis and Crohn's disease, and in patients who have had gastric bypass surgery and
may not be able to absorb enough Vitamin D. Vitamin D is also used to determine effectiveness of treatment when vitamin D, calcium, phosphorus, and/or magnesium
supplementation is prescribed. Reasons for suboptimal 25-OH-VitD levels include lack of sunshine exposure, inadequate intake; malabsorption eg, due to Celiac disease);
depressed hepatic vitamin D 25-hydroxylase activity, secondary to advanced liver disease; and enzyme-inducing drugs, in particular many antiepileptic drugs, including
phenytoin, phenobarbital, and carbamazepine, that increase 25-OH-VitD metabolism. In contrast to the high prevalence of 25-OH-VitD deficiency, hypervitaminosis D
is rare, and is only seen after prolonged exposure to extremely high doses of vitamin D. When it occurs, it can result in severe hypercalcemia and hyperphosphatemia.
Method : Fully Automated Bidirectionally Interfaced Electro Chemi Luminescent Immuno Assay
Page 8 of 8